Small Pharma Inc. (DMTTF)

0.1121 +0.0026 (+2.38%) At close: 03:59PM EDT

Small Pharma Inc.

6-8 Bonhill Street
3rd Floor
London EC2A 4BX
United Kingdom

https://www.smallpharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. George Tziras	CEO & Non-Independent Director	288.17k	N/A	N/A
Mr. Peter David Rands	Chief Innovation & Intellectual Property Officer, Founder and Director	338.95k	N/A	N/A
Mr. David Steel	Chief Financial Officer	281.27k	N/A	N/A
Dr. Carol Routledge	Chief Scientific & Medical Officer	351.9k	N/A	N/A
Ms. Marie Claire Layzell	Chief Manufacturing & Devel. Officer & Director	332.47k	N/A	N/A
Dr. Alastair James Riddell M.D., M.Sc., MBChB, MFPM, MRCGP, MSc, Ph.D.	Chief Operating Officer	N/A	N/A	1949
Mr. Richard M. Kimel HBA, LLB	Corp. Sec.	N/A	N/A	1967
Mr. Jim Rennie	Director of Devel. and Member of Scientific & Advisory Board	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. The company's clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. It is also developing a pipeline of proprietary preclinical assets. The company was founded in 2015 and is headquartered in London, the United Kingdom.

Corporate Governance

Small Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.